{"id":"W2979931387","doi":"10.1182/blood.v124.21.1659.1659","title":"No Increased Risk of Secondary Neoplasms in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma : A Meta-Analysis of 9 Trials","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; CD20; Clinical trial; Oncology; Hazard ratio; Clinical endpoint; Immunology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01645964,0.002990283,0.01888938,0.004565923,0.0006726165,0.004043621,0.002149233,0.00243233,0.004154873],"category_scores_gemma":[0.03065679,0.001518003,0.06106463,0.005215549,0.000821481,0.002176327,0.001535944,0.002738815,0.0005057488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002126303,"about_ca_system_score_gemma":0.001687563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003978682,"about_ca_topic_score_gemma":0.0074305,"domain_scores_codex":[0.9845304,0.007639476,0.004272314,0.001924401,0.001185975,0.000447422],"domain_scores_gemma":[0.9754799,0.01811967,0.003670049,0.001135485,0.001236568,0.0003583736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004578462,0.00001878246,0.003193459,0.07306517,0.9150161,0.0001149915,0.00002948022,0.0003783288,0.0001659723,0.00005815695,0.0002920306,0.00308913],"study_design_scores_gemma":[0.0009375696,0.0001497093,0.002338288,0.00319254,0.9924304,0.00005569992,0.00001582073,0.0001574077,0.00006974513,0.0001363318,0.0005038248,0.00001279514],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02140059,0.9742837,0.001376396,0.0003390783,0.0003877042,0.0003989394,0.001097412,0.00007563049,0.0006405092],"genre_scores_gemma":[0.6562359,0.3333527,0.00306463,0.002151218,0.0005220353,0.001459516,0.002172583,0.00014857,0.0008928173],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01888938,"threshold_uncertainty_score":0.08704793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02316821813579454,"score_gpt":0.2641002941934727,"score_spread":0.2409320760576782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}